Health Care & Hospital Law,
Civil Litigation
May 27, 2021
US judge rejects $2B Roundup deal, cites 'glaring flaws'
“The settlement proposed by these attorneys would accomplish a lot for Monsanto,” U.S. District Judge Vince Chhabria wrote. “It would accomplish far less for the Roundup users who have not been diagnosed with NHL — and not nearly as much as the attorneys pushing this deal contend.”
A federal judge turned down on Wednesday a proposed $2 billion deal to resolve future Roundup cases that he found unfairly favors Bayer-owned Monsanto.
U.S. District Judge Vince Chhabria identified "glaring flaws" in the settlement that he concluded is "clearly unreasonable" for people who have been exposed to the weed killer but have not developed non-Hodgkin's lymph...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Civil Litigation
Federal judge issues scathing rebuke of MDL fee ‘holdbacks’
By Gina Kim
Securities, Mergers & Acquisitions, Corporate, Civil Litigation
Bayer investors’ securities class action over Monsanto merger proceeds
By Malcolm Maclachlan
Civil Litigation, 9th U.S. Circuit Court of Appeals
9th Circuit affirms $25M verdict in Roundup cancer case
By Blaise Scemama
Legal Education, Law Practice
In conversation with UCLA Law Dean Jennifer Mnookin
By William Domnarski
Law Practice, Civil Litigation
Lead counsel fights other firms over Roundup fees
By Winston Cho
